← back to search

Meaghan Stirn

CytRx (United States) · US
Area of research
Biotechnology · Genetics
Research interest
Research interests include Cancer Research and Treatments, Virus-based gene therapy research, CAR-T cell therapy research, and Cancer Genomics and Diagnostics.
h-index
7
citations
329
works
26
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors
Future Oncology 2022cited by 14position: middledoi
Going viral: a review of replication-selective oncolytic adenoviruses
Oncotarget 2015cited by 133position: middledoi
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study
The Lancet Oncology 2015cited by 90position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 3 papers (2015–2022)Christopher Larson · Freedom to Live2 papers (2015–2022)— · 2 papers (2015–2015)— · 2 papers (2015–2015)Tony Reid · CytRx (United States)2 papers (2015–2022)— · 2 papers (2015–2015)Michelle M. Kim · Michigan United1 papers (2015–2015)Pedro Cabrales · University of San Diego1 papers (2015–2015)Lisle M. Nabell · University of Alabama at Birmingham1 papers (2022–2022)Corey A. Carter · Center for Cancer Research1 papers (2015–2015)Minal Barve · Mary Crowley Cancer Research Center1 papers (2022–2022)— · 1 papers (2015–2015)— · 1 papers (2015–2015)— · 1 papers (2022–2022)— · 1 papers (2022–2022)William L. Fitch · Palo Alto University1 papers (2015–2015)— · 1 papers (2022–2022)Victoria Villaflor · University of California, Irvine Medical Center1 papers (2022–2022)Santosh Kesari · Santa Monica College1 papers (2022–2022)— · 1 papers (2022–2022)